Items where Author is "Guha, IN"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
Athwal, VS
Pritchett, J 
ORCID: https://orcid.org/0000-0003-2620-7061
Llewellyn, J
Martin, K
Camacho, E
Raza, SMA
Phythian‐Adams, A
et al.
ORCID: https://orcid.org/0000-0003-2620-7061
Llewellyn, J
Martin, K
Camacho, E
Raza, SMA
Phythian‐Adams, A
et al.
Athwal, VS, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061, Llewellyn, J, Martin, K, Camacho, E, Raza, SMA, Phythian‐Adams, A, Birchall, LJ, Mullan, AF, Su, K, Pearmain, L, Dolman, G, Zaitoun, AM, Friedman, SL, MacDonald, A, Irving, WL, Guha, IN, Hanley, NA and Piper Hanley, K
(2017)
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
EMBO Molecular Medicine, 9 (12).
pp. 1696-1710.
ISSN 1757-4676
ORCID: https://orcid.org/0000-0003-2620-7061, Llewellyn, J, Martin, K, Camacho, E, Raza, SMA, Phythian‐Adams, A, Birchall, LJ, Mullan, AF, Su, K, Pearmain, L, Dolman, G, Zaitoun, AM, Friedman, SL, MacDonald, A, Irving, WL, Guha, IN, Hanley, NA and Piper Hanley, K
Pritchett, J, Harvey, E, Athwal, V, Berry, A, Rowe, C, Oakley, F, Moles, A, Mann, DA, Bobola, N, Sharrocks, AD, Thomson, BJ, Zaitoun, AM, Irving, WL, Guha, IN, Hanley, NA and Hanley, KP
(2012)
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.
Hepatology, 56 (3).
pp. 1108-1116.
ISSN 0270-9139